iRhythm Technologies Inc
(STU:I25)
€
79.5
-2 (-2.45%)
Market Cap: 2.51 Bil
Enterprise Value: 2.71 Bil
PE Ratio: 0
PB Ratio: 37.70
GF Score: 68/100 iRhythm Technologies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021 / 09:00PM GMT
Release Date Price:
€39.6
(-0.50%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the first day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley.
It's my pleasure to have iRhythm with us today. Doug Devine, Interim CEO and CFO; and Dan Wilson, EVP Strategy and Corporate Development. Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any question, please reach out to your Morgan Stanley sales representative.
And with that, Doug, Dan, thank you for joining us today.
Douglas J. Devine
iRhythm Technologies, Inc. - COO, CFO & Secretary
Hi, Cecilia.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot